Cargando…
Targeting the SARS-CoV-2 3CL(pro) and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885524/ https://www.ncbi.nlm.nih.gov/pubmed/33576273 http://dx.doi.org/10.2217/fca-2020-0201 |
| _version_ | 1783651623058276352 |
|---|---|
| author | Shirvaliloo, Milad |
| author_facet | Shirvaliloo, Milad |
| author_sort | Shirvaliloo, Milad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7885524 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Future Medicine Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78855242021-02-16 Targeting the SARS-CoV-2 3CL(pro) and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors Shirvaliloo, Milad Future Cardiol Commentary Future Medicine Ltd 2021-02-12 2021-01 /pmc/articles/PMC7885524/ /pubmed/33576273 http://dx.doi.org/10.2217/fca-2020-0201 Text en © 2021 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/) |
| spellingShingle | Commentary Shirvaliloo, Milad Targeting the SARS-CoV-2 3CL(pro) and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors |
| title | Targeting the SARS-CoV-2 3CL(pro) and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors |
| title_full | Targeting the SARS-CoV-2 3CL(pro) and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors |
| title_fullStr | Targeting the SARS-CoV-2 3CL(pro) and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors |
| title_full_unstemmed | Targeting the SARS-CoV-2 3CL(pro) and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors |
| title_short | Targeting the SARS-CoV-2 3CL(pro) and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors |
| title_sort | targeting the sars-cov-2 3cl(pro) and no/cgmp/pde5 pathway in covid-19: a commentary on pde5 inhibitors |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885524/ https://www.ncbi.nlm.nih.gov/pubmed/33576273 http://dx.doi.org/10.2217/fca-2020-0201 |
| work_keys_str_mv | AT shirvaliloomilad targetingthesarscov23clproandnocgmppde5pathwayincovid19acommentaryonpde5inhibitors |